Israel - English - Ministry of Health

novartis israel ltd - nepafenac - ophthalmic suspension - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Kenya - English - Pharmacy and Poisons Board

nepafenac ophthalmic suspension 0.1% w/v - eye drops, suspension - nepafenac 0.1 % w/v - nepafenac

Kenya - English - Pharmacy and Poisons Board

novartis pharma ag litchtstrasse 35, 4056 basel, switzerland - nepafenac - eye drops, suspension - nepafenac 1mg/ml (0.1%) - nepafenac

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - nepafenac 3 mg/ml - eye drops, suspension - 0.3 % - active: nepafenac 3 mg/ml excipient: benzalkonium chloride boric acid carbomer 974 carmellose sodium disodium edetate guar gum hydrochloric acid propylene glycol purified water sodium chloride sodium hydroxide - ilevro is indicated for the prevention and treatment of postoperative pain and inflammation associated with cataract surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - nepafenac 1 mg/ml - eye drops, suspension - 0.1 % - active: nepafenac 1 mg/ml excipient: benzalkonium chloride carbomer disodium edetate dihydrate hydrochloric acid mannitol purified water sodium chloride sodium hydroxide tyloxapol - inhibition and treatment of pain and inflammation associated with cataract surgery

Canada - English - Health Canada

novartis pharmaceuticals canada inc - nepafenac - suspension - 0.1% - nepafenac 0.1% - nonsteroidal anti-inflammatory agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - nepafenac - suspension - 0.3% - nepafenac 0.3% - nonsteroidal anti-inflammatory agents

Kenya - English - Pharmacy and Poisons Board

sun pharmaceutical industries limited sun house, plot no. 201 b/1 western express - nepafenac ophthalmic suspension - eye drops, suspension - each ml contains: nepafenac………….1.0 mg - nepafenac

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - nepafenac - suspension, sterile - 1.0 mg/ml - nepafenac 1.0 mg/ml

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.